A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

Nature Medicine

Volumn 11, Issue 11, 2005, Pages 1244-1249

  Reddy, Pavan ^a   Maeda, Yoshinobu ^a   Liu, Chen ^b   Krijanovski, Oleg I ^a   Korngold, Robert ^c   Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HOST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW TRANSPLANTATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; ISOANTIGENS; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 30744443483     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1309     Document Type: Article

References (30)

1. Appelbaum, F.R. Haematopoietic cell transplantation as immunotherapy. Nature 411, 385-389 (2001).
2. Shlomchik, W.D. et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285, 412-415 (1999).
3. Teshima, T. et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 8, 575-581 (2002).
4. Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002).
5. Jones, S.C., Murphy, G.F., Friedman, T.M. & Korngold, R. Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model. J. Clin. Invest. 112, 1880-1886 (2003).
6. Matte, C.C. et al. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10, 987-992 (2004).
7. Pardoll, D. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 21, 807-839 (2003).
8. Dunn, G.P., Old, L.J. & Schreiber, R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (2004).
9. Bleakley, M. & Riddell, S.R. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat. Rev. Cancer 4, 371-380 (2004).
10. Reddy, P. & Ferrara, J.L. Immunobiology of acute graft-versus-host disease. Blood Rev. 17, 187-194 (2003).
11. Duffner, U.A. et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J. Immunol. 172, 7393-7398 (2004).
12. Gatza, E. & Okada, C.Y. Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma. J. Immunol. 169, 5227-5235 (2002).
13. Patterson, A.E. & Korngold, R. Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following mouse hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7, 187-196 (2001).
14. Patterson, A.E. & Korngold, R. Cross-protective mouse graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines. Biol. Blood Marrow Transplant. 6, 537-547 (2000).
15. Zhang, Y., Louboutin, J.P., Zhu, J., Rivera, A.J. & Emerson, S.G. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109, 1335-1344 (2002).
16. Merad, M. et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10, 510-517 (2004).
17. Mapara, M.Y. & Sykes, M. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J. Clin. Oncol. 22, 1136-1151 (2004).
18. Li, J.M. & Waller, E.K. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 10, 540-551 (2004).
19. Kolb, H.J., Schmid, C., Barrett, A.J. & Schendel, D.J. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103, 767-776 (2004).
20. Huntly, B.J. & Gilliland, D.G. Cancer biology: summing up cancer stem cells. Nature 435, 1169-1170 (2005).
21. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000).
22. Reddy, P. et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus- leukemia effect. Proc. Natl Acad. Sci. USA 101, 3921-3926 (2004).
23. Bierman, P.J. et al. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation - The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 21, 3744-3753 (2003).
24. Wilson, N.S. & Villadangos, J.A. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 86, 241-305 (2005).
25. Eibl, B. et al. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosom. Cancer 20, 215-223 (1997).
26. Stelljes, M. et al. Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets. Blood 104, 1210-1216 (2004).
27. Fontaine, P. et al. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat. Med. 7, 789-794 (2001).
28. Auffermann-Gretzinger, S. et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 99, 1442-1448 (2002).
29. Kaech, S.M. & Ahmed, R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2, 415-422 (2001).
30. Mempel, T.R., Henrickson, S.E. & Von Andrian, U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154-159 (2004).